| risperidone / Generic mfg. |
NCT01363349: Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia |
|
|
| Terminated | 2b | 269 | Europe, RoW | CYP-1020, BL-1020, Risperidone | BioLineRx, Ltd. | Schizophrenia, Cognitive Effect on Schizophrenic Patients | 03/13 | 04/13 | | |
|
| Completed | 2 | 231 | US | talnetant, risperidone | GlaxoSmithKline | Schizophrenia | 04/03 | 04/03 | | |
NCT00300963: Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients |
|
|
| Completed | 2 | 275 | US | Talnetant | GlaxoSmithKline | Schizophrenia | 10/05 | 10/05 | | |
NCT00361166: Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone |
|
|
| Completed | 2 | 400 | US, RoW | ACP-103 | ACADIA Pharmaceuticals Inc. | Schizophrenia | | 03/07 | | |
| Completed | 2 | 7 | Europe | Pipamperone, Risperdal, Invega and Xeplion, Placebo | PharmaNeuroBoost N.V. | Chronic Schizophrenia, Schizoaffective Disorder | 11/12 | 12/12 | | |
NCT01272765: Anti-psychotic Medication (Stable Dose) Weight Loss Study |
|
|
| Withdrawn | 2 | 0 | US | Placebo, sugar pill, IHBG-10, IHBG10 | Avera McKennan Hospital & University Health Center | Obesity | 01/13 | 01/13 | | |
NCT01272752: Anti-psychotic Medication (New Use) Weight Loss Study |
|
|
| Withdrawn | 2 | 0 | US | IHBG-10, IHBG10, Placebo, sugar pill | Avera McKennan Hospital & University Health Center | Obesity | 12/13 | 12/13 | | |
